Your Product

Your Product

Back to main menu

Your Product

Services tailored to your product, ensuring the right development path, scalable processes, and consistent manufacturing outcomes.

Learn more
Your Stage

Your Stage

Back to main menu

Your Stage

At each stage, new challenges emerge. A single team and site ensure continuity and consistent execution across the product lifecycle.

Learn more
Our Services

Our Services

Back to main menu

Our Services

Integrated CDMO services designed for seamless progression from development through commercial manufacturing, under global regulatory standards.

Learn more
Resources

Resources

Back to main menu

Resources

Technical insights, practical guidance, and applied expertise to support decision‑making at every stage.

See all resources
About Us

About Us

Back to main menu

About Us

An overview of Groupe PARIMA, our mission, and our expertise in supporting the pharmaceutical industry.

Learn more
    En
    English
    Contact us

    Process Scale-up

    We align process intent with equipment capability to deliver consistent results from engineering runs to GMP batches.

    Drug Manufacturing banner

    Scale-up you can validate

    We translate development knowledge into robust, repeatable manufacturing performance.

    Process scale-up confirms that process parameters deliver consistent critical quality attributes at larger volumes. Groupe PARIMA defines critical process parameters, sets a practical control strategy, and documents a clear path to validation-ready manufacturing.

    Talk to our experts

    We turn development knowledge into scalable setpoints, in-process controls, and consistent performance at target volume.

    From Development to Manufacturing

    Groupe PARIMA combines formulation, analytics, and GMP execution to make technology transfer practical, traceable, and ready for manufacturing. 

    Card 01

    Critical scale drivers defined

    We connect CQAs to CPPs to focus scale-up work on what truly controls product performance.

    Card 02

    Process fit & equipment

    We scale laboratory development to commercial volumes by aligning equipment and process parameters to reproduce formulation performance.

    Card 03

    PARAMETER‑SETTING STUDIES

    We use systematic trials to define operating ranges and prepare process parameters for repeatability at the intended scale.

    Card 04

    Control strategy inputs

    We define in-process controls, sampling plan, and acceptance criteria aligned with GMP expectations.

    Card 05

    Transfer-ready documentation

    We generate clear batch instructions and process rationale to support smooth tech transfer and validation execution.

    From development to target volume

    We translate development knowledge into equipment‑fit processing, defined CPPs, and scale‑up data that prepare processes for repeatability and validation planning.

    01
    Card 01

    Clinical lot

    We manufacture flexible clinical lots ranging from 2 to 4,000 L to support early‑phase studies and evolving formulation needs.

    02
    Card 02

    Stability Studies

    Stability studies generate data to support formulation optimization and enable progression to clinical and regulatory milestones.

    03
    Card 03

    Exhibit Batch

    Exhibit batches are produced at appropriate scales to support regulatory submissions and demonstrate formulation robustness.

    04
    Card 04

    Engineering Lot

    Engineering lots are used to refine equipment selection and process parameters in preparation for scale‑up and validation.

    05
    Card 05

    Analytical Method

    We transfer and qualify fit‑for‑purpose test methods with clear system suitability, sampling, and reporting expectations.

    Resources

    Explore practical guidance that supports technology transfer into GMP execution for non‑sterile drug products

    Groupe PARIMA
    How Drug Product Formulation Works: Topical, Oral, and Nasal Liquid and Semi-Solid Dosage Forms
    Read more
    Groupe PARIMA
    How Early API Characterization Can Reduce Formulation and Scale-up Risks
    Read more
    Groupe PARIMA
    Topical 101: A Guide to Complex Dermatology Formulation Development
    Read more
    Groupe PARIMA
    How Drug Product Formulation Works: Topical, Oral, and Nasal Liquid and Semi-Solid Dosage Forms
    Read more
    Groupe PARIMA
    How Early API Characterization Can Reduce Formulation and Scale-up Risks
    Read more
    Groupe PARIMA
    Topical 101: A Guide to Complex Dermatology Formulation Development
    Read more

    See all Resources

    Contact us

    Prepare for GMP execution

    Let’s scope your tech transfer and align process, methods, and documentation into execution-ready deliverables at Groupe PARIMA.